Approval

Weekly Digest – September 2025 Weekly Digest – September 2025 01 September 2025: Zai Lab announces approval of TIVDAK for patients with recurrent or metastatic cervical cancer in Hong Kong  Zai Lab announced that the Hong Kong Department of Health […]

by Sandhya Ramalingam

Continue Reading

Weekly Digest – September 2025 Weekly Digest – September 2025 02 September 2025: Health Canada approves ELAHERE for certain types of platinum resistant ovarian cancers Health Canada has approved ELAHERE (mirvetuximab soravtansine), an antibody-drug conjugate, for adult patients with folate […]

by Sandhya Ramalingam

Continue Reading